LineaGen Inc. hopes to parlay its efforts to identify rare autism-linked genetic variants into a testing business built around a microarray-based autism spectrum disorder diagnostic.

The company recently launched its firststepDX autism testing kit, a chromosomal microarray bundled with a genetic counseling service to aid in diagnosing young children with developmental delay or intellectual disability, which are early clinical signs of autism spectrum disorder.